As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/26/04  Gordon Carl L                     3          Director²   1:9K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Binder Gordon M                   3          Director²   1:9K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Walton Alan G                     3          Dir.,%Own.² 1:6K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  van Osch Martien                  3          Director²   1:6K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Tolf Bo-Ragnar                    3          Officer²    1:8K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Richards Douglas E                3          Officer²    1:7K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Rasmussen Torsten                 3          Director²   1:8K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Barnes Jeffrey T                  3          10% Owner²  1:13K  Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
          Carthy Mark
          Fleming Jonathan
          Lytton Michael
          Mrna Fund II LP
          Obp Management IV LP
          Oxford Bioscience Partners IV LP
 5/26/04  Kaplan Lester J PhD               3          Director²   1:7K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Iversen Leslie L                  3          Director²   1:9K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Hacksell Uli                      3          Dir.,Off.²  1:10K  Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Binder Gordon M                   3          Director²   1:9K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Davis Robert E                    3          Officer²    1:5K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Brann Mark R                      3          Dir.,Off.²  1:9K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Binder Gordon M                   3          Director²   1:6K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Aasen Thomas H                    3          Officer²    1:8K   Acadia Pharmaceuticals Inc.       Calderon Law Group PC    
 5/26/04  Acadia Pharmaceuticals Inc.       S-1/A                  2:1.5M                                   Donnelley … Solutions/FA 

____________
¹	Filing/Form Types:  -K
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	S-1	Registration Statement (General Form) — Form S-1.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
	F	This Filing was Deleted by the SEC, but not by SEC Info℠.  See our Deletion Policy.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.